Vigene Biosciences’ Chief Commercial Officer, Dr. Jeffrey Hung, will be speaking on a panel at the new BPI COVID-19 Therapeutic Development & Production conference this year to discuss unprecedented collaborations, progress and initiatives related to COVID-19 treatments and vaccine development. Dr. Hung’s co-panelists will include other bioprocessing thought leaders.
BPI’s COVID-19 Therapeutic Development & Production conference is a virtual conference from April 27 – 28, 2021. Vigene Biosciences’ panel will be presented during the Collaborations to Expedite Vaccine & Therapeutic Production section on April 28, 2021 at 13:15 – 13:45 BST.
To register for this conference, visit BPI’s COVID-19 Therapeutic Development & Production’s site. To learn more about Vigene’s COVID-19 Therapeutic tools, visit our page.